Novel Drugs Targeting the Epidermal Growth Factor Receptor and Its Downstream Pathways in the Treatment of Colorectal Cancer: A Systematic Review

Table 2

Phase 3 clinical trials of erlotinib in colorectal cancer.

Study	Number of enrollment	Expected date of completion	NCT identifier
Chemotherapy and Avastin followed by maintenance treatment with Avastin ± Tarceva	240	December 2011	NCT 00598156
Combination chemotherapy and bevacizumab ± erlotinib in unresectable mCRC	640	Unknown	NCT00265824